OBJECTIVE: To describe the characteristics and management of Diabetes mellitus (DM) patients from low- and middle-income countries (LMIC). METHODS: We systematically characterised consecutive DM patients attending public health services in urban settings in Indonesia, Peru, Romania and South Africa, collecting data on DM treatment history, complications, drug treatment, obesity, HbA1c and cardiovascular risk profile; and assessing treatment gaps against relevant national guidelines. RESULTS: Patients (median 59 years, 62.9% female) mostly had type 2 diabetes (96%), half for >5 years (48.6%). Obesity (45.5%) and central obesity (females 84.8%; males 62.7%) were common. The median HbA1c was 8.7% (72 mmol/mol), ranging from 7.7% (61 mmol/mol; ...
Background: Previous reports suggest that currently available drugs used in the treatment of type 2 ...
Background Diabetes mellitus is one of the leading causes of death and disability worldwide. Approxi...
Introduction: Diabetes mellitus type 2 (DM2) is a chronic metabolic disease frequently associated wi...
OBJECTIVE: To describe the characteristics and management of Diabetes mellitus (DM) patients from lo...
To describe the characteristics and management of Diabetes mellitus (DM) patients from low- and midd...
OBJECTIVE: To describe the characteristics and management of Diabetes mellitus (DM) patients from lo...
Introduction: WHO estimates 422 million cases of diabetes mellitus worldwide. Mozambique has the sec...
Middle-income countries need a rational and cost-effective approach to optimise management of type 2...
The prevalence of diabetes is increasing rapidly in low- and middle-income countries (LMICs), urgent...
Approximately 80% of the 463 million adults worldwide with diabetes live in low- and middle-income c...
Aims: To improve access and quality of diabetes care for people in low-income countries, it is impor...
The International Diabetes Mellitus Practice Study is a 5-year survey documenting changes in diabete...
ABSTRACTBackground: Previous reports suggest that currently available drugs used in the treatmentof ...
Introduction Trends on glycemic control and diabetes complications are known for high-income countri...
Background: Globally, the number of people living with Diabetes Mellitus (DM) has increased four-fol...
Background: Previous reports suggest that currently available drugs used in the treatment of type 2 ...
Background Diabetes mellitus is one of the leading causes of death and disability worldwide. Approxi...
Introduction: Diabetes mellitus type 2 (DM2) is a chronic metabolic disease frequently associated wi...
OBJECTIVE: To describe the characteristics and management of Diabetes mellitus (DM) patients from lo...
To describe the characteristics and management of Diabetes mellitus (DM) patients from low- and midd...
OBJECTIVE: To describe the characteristics and management of Diabetes mellitus (DM) patients from lo...
Introduction: WHO estimates 422 million cases of diabetes mellitus worldwide. Mozambique has the sec...
Middle-income countries need a rational and cost-effective approach to optimise management of type 2...
The prevalence of diabetes is increasing rapidly in low- and middle-income countries (LMICs), urgent...
Approximately 80% of the 463 million adults worldwide with diabetes live in low- and middle-income c...
Aims: To improve access and quality of diabetes care for people in low-income countries, it is impor...
The International Diabetes Mellitus Practice Study is a 5-year survey documenting changes in diabete...
ABSTRACTBackground: Previous reports suggest that currently available drugs used in the treatmentof ...
Introduction Trends on glycemic control and diabetes complications are known for high-income countri...
Background: Globally, the number of people living with Diabetes Mellitus (DM) has increased four-fol...
Background: Previous reports suggest that currently available drugs used in the treatment of type 2 ...
Background Diabetes mellitus is one of the leading causes of death and disability worldwide. Approxi...
Introduction: Diabetes mellitus type 2 (DM2) is a chronic metabolic disease frequently associated wi...